Mutations in the tyrosine kinase domain of the EGFR gene are rare in the Korean Oral Squamous Cell Carcinoma
[journal] Luka Milas / 2003 / Chemoradiotherapy: Emerging treatment improvement strategies / Head & Neck / Wiley-Blackwell 25 (2) : 152~167 / https://doi.org/10.1002/hed.10232
[journal] C. J. Langer / 2012 / Exploring Biomarkers in Head and Neck Cancer / Cancer 118 (16) : 3882~3892
[journal] E. S. Lampri / 2015 / Biomarkers of head and neck cancer, tools or a gordian knot? / Int J Clin Exp Med 8 (7) : 10340~10357
[journal] S. P. D’Angelo / 2011 / Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas / J Clin Oncol 29 : 2066~2070
[journal] A. F. Gazdar / 2009 / Activating and resistance mutations of EGFR in non-small-cell lung cancer : role in clinical response to EGFR tyrosine kinase inhibitors / Oncogene 28 : 24~31
[journal] F. Ciardiello / 2001 / A novel approach in the treatment of cancer : targeting the epidermal growth factor receptor / Clin Cancer Res 7 : 2958~2970
[journal] Q. Liu / 2013 / Lack of epidermal growth factor receptor gene mutations in exons 19 and 21 in primary lymphoepithelioma-like carcinoma of the lung / Thoracic Cancer 5 : 63~67
[journal] P. Stephens / 2004 / Lung cancer : intragenic ERBB2 kinase mutations in tumors / Nature 431 : 525~526
[journal] H. Shigematsu / 2005 / Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers / J Natl Cancer Inst 97 : 339~462
[journal]
이은주
/ 2005
/
Characterization of newly established oral cancer cell lines derived fromsix squamous cell carcinoma and two mucoepidermoid carcinoma cells
/ Experimental and Molecular Medicine
/ 생화학분자생물학회
37
(5)
: 379~390
[journal]
전남경
/ 2014
/
The GSK-3β/Cyclin D1 Pathway is Involved in the Resistance of Oral Cancer Cells to the EGFR Tyrosine Kinase Inhibitor ZD1839
/ 대한의생명과학회지
/ 대한의생명과학회
20
(2)
: 85~95
[journal] S. Rajendran / 2013 / Lack of RING finger domain(RFD)mutations of the c-cbl gene in oral squamous cell carcinomas in Chennai, India / Asian Pac J Cancer Prev 14 : 1073~1075
[journal] E. E. Cohen / 2003 / Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck / J Clin Oncol 21 : 1980~1987
[book] P. M. Harari / 2003 / Molecular Targeting of the Epidermal Growth Factor Receptor / Lippincott, Williams and Wilkings
[journal] T. Fukui / 2007 / Gefitinib and epidermal growth factor receptor gene mutation / Gan Kagaku Ryoho 34 : 1168~1172
[journal] A. F. Gazdar / 2004 / Mutations and addiction to EGFR : the Achilles heal of lung cancers? / Trends Mol Med 10 : 481~486
[journal] E. E. Cohen / 2005 / Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR / Clin Cancer Res 11 : 8105~8108
[journal] S. E. Wang / 2006 / HER2kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors / Cancer Cell 10 : 25~38
[journal] Y. Lemos-González / 2007 / Absence of activating mutations in the EGFR kinase domain in Spanish head and neck cancer patients / Tumour Biol 28 : 273~279
[journal] J. Loeffler-Ragg / 2006 / Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma / Eur J Cancer 42 : 109~111
[journal] J. W. Lee / 2006 / Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer / Int J Cancer 113 : 510~511
KCI Citation (0)